BD

Bheekaram Devasi

Active Director Director DIN 08776613
DIN 08776613 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Bheekaram Devasi

Data last updated:

Bheekaram Devasi is a Director at Miotic Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Miotic Pharmaceutical Private Limited reported revenue of ₹4.25 Cr (FY 2025).

DIN 08776613
Primary Designation Director
Industry Pharma
First Appointment 30 Jun 2020
Oldest Company Age 6 yrs
Largest company Miotic Pharmaceutical Private Limited · ₹4.25 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jun 20202020₹4.25 Cr (FY 2025)Active

Board colleagues of Bheekaram Devasi

Directorship timeline

Open interactive timeline →
Miotic Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bheekaram Devasi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bheekaram Devasi

Bheekaram Devasi currently holds 1 directorship: Miotic Pharmaceutical Private Limited (Director, since 30 Jun 2020, revenue ₹4.25 Cr (FY 2025)).

Bheekaram Devasi was first appointed on 30 Jun 2020 as Director at Miotic Pharmaceutical Private Limited.

The current boards of Bheekaram Devasi's companies include Anita Narendra Barlota (Miotic Pharmaceutical Private Limited), Mishri Lal (Miotic Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available